FDA
label_change
· 2026-01-20
FDA Approved: ZIRGAN — Supplemental Application (Bausch & Lomb Incorporated)
Summary
The FDA approved a supplemental application for ZIRGAN (ganciclovir ophthalmic gel) from Bausch & Lomb Incorporated, resulting in labeling changes related to it…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZIRGAN (GANCICLOVIR)